Biotron Limited reported earnings results for the full year ended June 30, 2023. For the full year, the company reported net loss was AUD 3.49 million compared to AUD 2.78 million a year ago. Basic loss per share from continuing operations was AUD 0.0043 compared to AUD 0.004 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.057 AUD | +1.79% | -16.18% | -41.24% |
Apr. 05 | Biotron Meets Primary Objectives of Phase Two HIV Trial; Shares Surge 25% | MT |
Feb. 26 | Biotron Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-41.24% | 33.14M | |
-3.24% | 102B | |
+1.68% | 96.29B | |
+2.13% | 22.18B | |
-15.73% | 21.2B | |
-9.21% | 18.31B | |
-39.98% | 17.38B | |
-14.52% | 16.36B | |
+5.76% | 13.97B | |
+33.83% | 12.17B |
- Stock Market
- Equities
- BIT Stock
- News Biotron Limited
- Biotron Limited Reports Earnings Results for the Full Year Ended June 30, 2023